文献速递艾滋病与性传播感染细菌感染、耐药与抗菌药物

HIV感染与非HIV感染者血浆蛋白调控差异及他汀类药物效应:蛋白质组学分析

Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach.
PubMed 文献 · J Infect Dis · 2020-01-01

本研究采用高特异性蛋白质组学方法(Protein Extension Assay),在INTREPID试验的89例HIV感染者及46例非HIV但中心性肥胖和胰岛素抵抗的参与者中,评估匹伐他汀钙对350余种血浆蛋白的影响。结果显示,HIV感染者中PCOLCE显著升高、PLA2G7降低;非HIV者中整合素αM和防御素α-1升高、PLA2G7降低;基线时两组差异蛋白涉及血小板、内皮功能及免疫激活。

要点

  • 匹伐他汀可影响血小板和内皮功能及免疫激活相关蛋白。
  • HIV感染者中PCOLCE升高、PLA2G7降低。
  • 非HIV者中整合素αM和防御素α-1升高、PLA2G7降低。

核心结论

  • 匹伐他汀影响血小板和内皮功能及免疫激活相关蛋白,且在HIV感染者与非HIV者中的效应存在一定差异。

研究设计与样本

  • 采用Protein Extension Assay蛋白质组学方法,在INTREPID试验的89例HIV感染者及46例非HIV但中心性肥胖和胰岛素抵抗的参与者中评估匹伐他汀钙对350余种血浆蛋白的影响。
  • 两项研究均排除有心血管疾病史者。

主要发现

  • HIV感染者中,匹伐他汀治疗后PCOLCE显著升高,PLA2G7降低。
  • 非HIV参与者中,匹伐他汀治疗后整合素αM和防御素α-1升高,PLA2G7降低。
  • 基线时,HIV感染者与非HIV者差异表达的蛋白涉及血小板和内皮功能及免疫激活。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People with human immunodeficiency virus (PWH) demonstrate increased atherosclerotic cardiovascular disease (ASCVD). Statins are being studied to prevent ASCVD in human immunodeficiency virus (HIV), but little is known regarding the effects of statins on a broad range of inflammatory and cardiovascular proteins in this population. METHODS: We used a highly specific discovery proteomic approach (Protein Extension Assay), to determine statin effects on over 350 plasma proteins in relevant ASCVD pathways among HIV and non-HIV groups. Responses to pitavastatin calcium were assessed in 89 PWH in the INTREPID trial and 46 non-HIV participants with features of central adiposity and insulin resistance. History of cardiovascular disease was exclusionary for both studies. RESULTS: Among participants with HIV, PCOLCE (enzymatic cleavage of type I procollagen) significantly increased after pitavastatin therapy and PLA2G7 (systemic marker of arterial inflammation) decreased. Among participants without HIV, integrin subunit alpha M (integrin adhesive function) and defensin alpha-1 (neutrophil function) increased after pitavastatin therapy and PLA2G7 decreased. At baseline, comparing participants with and without HIV, differentially expressed proteins included proteins involved in platelet and endothelial function and immune activation. CONCLUSIONS: Pitavastatin affected proteins important to platelet and endothelial function and immune activation, and effects differed to a degree within PWH and participants without HIV.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. deFilippi C, Toribio M, Wong LP, et al. Differential Plasma Protein Regulation and Statin Effects in Human Immunodeficiency Virus (HIV)-Infected and Non-HIV-Infected Patients Utilizing a Proteomics Approach. J Infect Dis. 2020. PMID: 32310273. doi:10.1093/infdis/jiaa196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。